Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia

Davide Rossi, Valeria Spina, Riccardo Bomben, Silvia Rasi, Michele Dal-Bo, Alessio Bruscaggin, Francesca Maria Rossi, Sara Monti, Massimo Degan, Carmela Ciardullo, Roberto Serra, Antonella Zucchetto, Josep Nomdedeu, Pietro Bulian, Alberto Grossi, Francesco Zaja, Gabriele Pozzato, Luca Laurenti, Dimitar G. Efremov, Francesco Di-RaimondoRoberto Marasca, Francesco Forconi, Giovanni Del Poeta, Gianluca Gaidano, Valter Gattei

Research output: Contribution to journalArticle

Abstract

Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocytic leukemia (CLL). However, scant data are available on preferential associations between specific genetic alterations and stereotyped BCR subsets. By analyzing 1419 cases, 2 CLL subsets (2 and 8) harboring stereotyped BCR are enriched in specific molecular alterations influencing disease course. SF3B1 mutations are the genetic hallmark of IGHV3-21-CLL belonging to subset 2 (52%) but are evenly represented in nonstereotyped IGHV3-21-CLL. Trisomy 12 (87%) and NOTCH1 mutations (62%) characterize IGHV4-39-CLL belonging to subset 8 but occur with the expected frequency in IGHV4-39-CLL with heterogeneous BCR. Clinically, co-occurrence of SF3B1 mutations and subset 2 BCR configuration prompts disease progression in IGHV3-21-CLL, whereas cooperation between NOTCH1 mutations, +12, and subset 8 BCR configuration invariably primes CLL transformation into Richter syndrome. These findings provide a proof of concept that specific stereotyped BCR may promote or selectmolecular lesions influencing outcome.

Original languageEnglish
Pages (from-to)4902-4905
Number of pages4
JournalBlood
Volume121
Issue number24
DOIs
Publication statusPublished - Jun 13 2013

Fingerprint

B-Lymphocyte Subsets
B-Cell Chronic Lymphocytic Leukemia
Cells
B-Lymphocytes
Mutation
Trisomy
Disease Progression

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. / Rossi, Davide; Spina, Valeria; Bomben, Riccardo; Rasi, Silvia; Dal-Bo, Michele; Bruscaggin, Alessio; Rossi, Francesca Maria; Monti, Sara; Degan, Massimo; Ciardullo, Carmela; Serra, Roberto; Zucchetto, Antonella; Nomdedeu, Josep; Bulian, Pietro; Grossi, Alberto; Zaja, Francesco; Pozzato, Gabriele; Laurenti, Luca; Efremov, Dimitar G.; Di-Raimondo, Francesco; Marasca, Roberto; Forconi, Francesco; Del Poeta, Giovanni; Gaidano, Gianluca; Gattei, Valter.

In: Blood, Vol. 121, No. 24, 13.06.2013, p. 4902-4905.

Research output: Contribution to journalArticle

Rossi, D, Spina, V, Bomben, R, Rasi, S, Dal-Bo, M, Bruscaggin, A, Rossi, FM, Monti, S, Degan, M, Ciardullo, C, Serra, R, Zucchetto, A, Nomdedeu, J, Bulian, P, Grossi, A, Zaja, F, Pozzato, G, Laurenti, L, Efremov, DG, Di-Raimondo, F, Marasca, R, Forconi, F, Del Poeta, G, Gaidano, G & Gattei, V 2013, 'Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia', Blood, vol. 121, no. 24, pp. 4902-4905. https://doi.org/10.1182/blood-2013-02-486209
Rossi, Davide ; Spina, Valeria ; Bomben, Riccardo ; Rasi, Silvia ; Dal-Bo, Michele ; Bruscaggin, Alessio ; Rossi, Francesca Maria ; Monti, Sara ; Degan, Massimo ; Ciardullo, Carmela ; Serra, Roberto ; Zucchetto, Antonella ; Nomdedeu, Josep ; Bulian, Pietro ; Grossi, Alberto ; Zaja, Francesco ; Pozzato, Gabriele ; Laurenti, Luca ; Efremov, Dimitar G. ; Di-Raimondo, Francesco ; Marasca, Roberto ; Forconi, Francesco ; Del Poeta, Giovanni ; Gaidano, Gianluca ; Gattei, Valter. / Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. In: Blood. 2013 ; Vol. 121, No. 24. pp. 4902-4905.
@article{9d8fb7b8949e49dcaacfab07c814ac33,
title = "Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia",
abstract = "Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocytic leukemia (CLL). However, scant data are available on preferential associations between specific genetic alterations and stereotyped BCR subsets. By analyzing 1419 cases, 2 CLL subsets (2 and 8) harboring stereotyped BCR are enriched in specific molecular alterations influencing disease course. SF3B1 mutations are the genetic hallmark of IGHV3-21-CLL belonging to subset 2 (52{\%}) but are evenly represented in nonstereotyped IGHV3-21-CLL. Trisomy 12 (87{\%}) and NOTCH1 mutations (62{\%}) characterize IGHV4-39-CLL belonging to subset 8 but occur with the expected frequency in IGHV4-39-CLL with heterogeneous BCR. Clinically, co-occurrence of SF3B1 mutations and subset 2 BCR configuration prompts disease progression in IGHV3-21-CLL, whereas cooperation between NOTCH1 mutations, +12, and subset 8 BCR configuration invariably primes CLL transformation into Richter syndrome. These findings provide a proof of concept that specific stereotyped BCR may promote or selectmolecular lesions influencing outcome.",
author = "Davide Rossi and Valeria Spina and Riccardo Bomben and Silvia Rasi and Michele Dal-Bo and Alessio Bruscaggin and Rossi, {Francesca Maria} and Sara Monti and Massimo Degan and Carmela Ciardullo and Roberto Serra and Antonella Zucchetto and Josep Nomdedeu and Pietro Bulian and Alberto Grossi and Francesco Zaja and Gabriele Pozzato and Luca Laurenti and Efremov, {Dimitar G.} and Francesco Di-Raimondo and Roberto Marasca and Francesco Forconi and {Del Poeta}, Giovanni and Gianluca Gaidano and Valter Gattei",
year = "2013",
month = "6",
day = "13",
doi = "10.1182/blood-2013-02-486209",
language = "English",
volume = "121",
pages = "4902--4905",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "24",

}

TY - JOUR

T1 - Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia

AU - Rossi, Davide

AU - Spina, Valeria

AU - Bomben, Riccardo

AU - Rasi, Silvia

AU - Dal-Bo, Michele

AU - Bruscaggin, Alessio

AU - Rossi, Francesca Maria

AU - Monti, Sara

AU - Degan, Massimo

AU - Ciardullo, Carmela

AU - Serra, Roberto

AU - Zucchetto, Antonella

AU - Nomdedeu, Josep

AU - Bulian, Pietro

AU - Grossi, Alberto

AU - Zaja, Francesco

AU - Pozzato, Gabriele

AU - Laurenti, Luca

AU - Efremov, Dimitar G.

AU - Di-Raimondo, Francesco

AU - Marasca, Roberto

AU - Forconi, Francesco

AU - Del Poeta, Giovanni

AU - Gaidano, Gianluca

AU - Gattei, Valter

PY - 2013/6/13

Y1 - 2013/6/13

N2 - Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocytic leukemia (CLL). However, scant data are available on preferential associations between specific genetic alterations and stereotyped BCR subsets. By analyzing 1419 cases, 2 CLL subsets (2 and 8) harboring stereotyped BCR are enriched in specific molecular alterations influencing disease course. SF3B1 mutations are the genetic hallmark of IGHV3-21-CLL belonging to subset 2 (52%) but are evenly represented in nonstereotyped IGHV3-21-CLL. Trisomy 12 (87%) and NOTCH1 mutations (62%) characterize IGHV4-39-CLL belonging to subset 8 but occur with the expected frequency in IGHV4-39-CLL with heterogeneous BCR. Clinically, co-occurrence of SF3B1 mutations and subset 2 BCR configuration prompts disease progression in IGHV3-21-CLL, whereas cooperation between NOTCH1 mutations, +12, and subset 8 BCR configuration invariably primes CLL transformation into Richter syndrome. These findings provide a proof of concept that specific stereotyped BCR may promote or selectmolecular lesions influencing outcome.

AB - Genetic lesions and B-cell receptor (BCR) signaling are both oncogenic drivers in chronic lymphocytic leukemia (CLL). However, scant data are available on preferential associations between specific genetic alterations and stereotyped BCR subsets. By analyzing 1419 cases, 2 CLL subsets (2 and 8) harboring stereotyped BCR are enriched in specific molecular alterations influencing disease course. SF3B1 mutations are the genetic hallmark of IGHV3-21-CLL belonging to subset 2 (52%) but are evenly represented in nonstereotyped IGHV3-21-CLL. Trisomy 12 (87%) and NOTCH1 mutations (62%) characterize IGHV4-39-CLL belonging to subset 8 but occur with the expected frequency in IGHV4-39-CLL with heterogeneous BCR. Clinically, co-occurrence of SF3B1 mutations and subset 2 BCR configuration prompts disease progression in IGHV3-21-CLL, whereas cooperation between NOTCH1 mutations, +12, and subset 8 BCR configuration invariably primes CLL transformation into Richter syndrome. These findings provide a proof of concept that specific stereotyped BCR may promote or selectmolecular lesions influencing outcome.

UR - http://www.scopus.com/inward/record.url?scp=84881266955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881266955&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-02-486209

DO - 10.1182/blood-2013-02-486209

M3 - Article

C2 - 23637131

AN - SCOPUS:84881266955

VL - 121

SP - 4902

EP - 4905

JO - Blood

JF - Blood

SN - 0006-4971

IS - 24

ER -